AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Nike
NKE
|
+$421M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Qualcomm
QCOM
|
+$276M |
| 4 |
Illumina
ILMN
|
+$275M |
| 5 |
International Flavors & Fragrances
IFF
|
+$251M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$370M |
| 2 |
Apple
AAPL
|
+$329M |
| 3 |
Biogen
BIIB
|
+$316M |
| 4 |
Booking.com
BKNG
|
+$216M |
| 5 |
CELG
Celgene Corp
CELG
|
+$194M |
Sector Composition
| 1 | Technology | 18.47% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 15.34% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Eventbrite
EB
$265M
| $926K | ﹤0.01% |
45,900
| – | – |
|
|
SRNE
2302
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $924K | ﹤0.01% |
273,400
+100,000
| +58% | +$338K |
|
|
GOOD
2303
Gladstone Commercial Corp
GOOD
$610M
| $915K | ﹤0.01% |
41,870
+100
| +0.2% | +$2.19K |
|
2304
Surgery Partners
SGRY
$2.83B
| $914K | ﹤0.01% |
58,400
| – | – |
|
2305
Columbus McKinnon
CMCO
$428M
| $913K | ﹤0.01% |
22,800
| – | – |
|
2306
BGC Group
BGC
$4.84B
| $911K | ﹤0.01% |
153,290
+20,312
| +15% | +$121K |
|
|
AMAG
2307
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $911K | ﹤0.01% |
74,853
-10,400
| -12% | -$127K |
|
2308
TechTarget
TTGT
$429M
| $907K | ﹤0.01% |
34,770
+200
| +0.6% | +$5.22K |
|
|
PDLI
2309
DELISTED
PDL BioPharma, Inc.
PDLI
| $903K | ﹤0.01% |
278,222
| – | – |
|
2310
Atara Biotherapeutics
ATRA
$85.4M
| $900K | ﹤0.01% |
2,186
| – | – |
|
|
HT
2311
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $899K | ﹤0.01% |
61,760
-3,980
| -6% | -$57.9K |
|
|
AAWW
2312
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $899K | ﹤0.01% |
32,622
-1,099,872
| -97% | -$30.3M |
|
2313
Veeco
VECO
$1.54B
| $896K | ﹤0.01% |
61,012
+320
| +0.5% | +$4.7K |
|
2314
ANI Pharmaceuticals
ANIP
$2.14B
| $894K | ﹤0.01% |
14,500
+50
| +0.3% | +$3.08K |
|
2315
Grupo Aval
AVAL
$4.02B
| $894K | ﹤0.01% |
102,530
| – | – |
|
2316
Astronics
ATRO
$1.43B
| $893K | ﹤0.01% |
31,960
+800
| +3% | +$22.4K |
|
2317
Buckle
BKE
$3.15B
| $892K | ﹤0.01% |
33,002
-1,907
| -5% | -$51.5K |
|
2318
Gorman-Rupp
GRC
$1.15B
| $890K | ﹤0.01% |
23,745
+296
| +1% | +$11.1K |
|
2319
AngioDynamics
ANGO
$445M
| $884K | ﹤0.01% |
55,200
-35,770
| -39% | -$573K |
|
2320
ATN International
ATNI
$250M
| $878K | ﹤0.01% |
15,860
+100
| +0.6% | +$5.54K |
|
2321
Quince Therapeutics
QNCX
$84.9M
| $876K | ﹤0.01% |
15,600
+6,400
| +70% | +$359K |
|
2322
Middlefield Banc Corp
MBCN
$243M
| $875K | ﹤0.01% |
+33,526
| New | +$875K |
|
2323
Universal Electronics
UEIC
$64M
| $874K | ﹤0.01% |
16,720
+100
| +0.6% | +$5.23K |
|
2324
Select Water Solutions
WTTR
$954M
| $873K | ﹤0.01% |
94,032
-709
| -0.7% | -$6.58K |
|
|
LBAI
2325
DELISTED
Lakeland Bancorp Inc
LBAI
| $870K | ﹤0.01% |
50,045
| – | – |
|